|
Volumn 31, Issue 1, 2012, Pages 1-2
|
Buprenorphine in the treatment of heroin addiction: Déjà vu all over again
a
a
NONE
|
Author keywords
[No Author keywords available]
|
Indexed keywords
BENZODIAZEPINE;
BUPRENORPHINE;
BUPRENORPHINE PLUS NALOXONE;
COCAINE;
DIAMORPHINE;
METHADONE;
MORPHINE;
NARCOTIC AGENT;
OPIATE;
OPIATE ANTAGONIST;
PENTAZOCINE;
STREET DRUG;
SUBUXONE;
UNCLASSIFIED DRUG;
ADVERTIZING;
AUSTRALIA;
DEATH;
DRUG ABUSE;
DRUG DEPENDENCE TREATMENT;
DRUG FORMULATION;
DRUG MARKETING;
DRUG MISUSE;
DRUG MONITORING;
DRUG TRAFFIC;
DRUG URINE LEVEL;
EDITORIAL;
EMERGENCY TREATMENT;
HEROIN DEPENDENCE;
HUMAN;
INGESTION;
INTOXICATION;
LAW ENFORCEMENT;
MEDICAL SOCIETY;
METHADONE TREATMENT;
OPIATE ADDICTION;
PRESCRIPTION;
PRISON;
RESPIRATION DEPRESSION;
TABLET FORMULATION;
UNITED KINGDOM;
UNITED STATES;
WITHDRAWAL SYNDROME;
BUPRENORPHINE;
HEROIN DEPENDENCE;
HUMANS;
NARCOTIC ANTAGONISTS;
OPIATE SUBSTITUTION TREATMENT;
|
EID: 84858130877
PISSN: 10550887
EISSN: 15450848
Source Type: Journal
DOI: 10.1080/10550887.2011.643179 Document Type: Editorial |
Times cited : (1)
|
References (10)
|